- New
FOR RESEARCH PURPOSES ONLY
LYOPHILIZED POWDER VIAL
WILL REQUIRE RECONSTITUTION WITH BACTERIOSTATIC WATER, SOLD SEPARATELY
Disclaimer
Delivery & Returns
Secure Payments
💉 Tirzepatide — Research Peptide
Tirzepatide is a synthetic research peptide developed as a dual GIP and GLP-1 receptor agonist, studied for its potential role in glucose metabolism, weight regulation, and metabolic optimization.
Research Focus & Mechanism
• Dual receptor activation:
o GIP (Glucose-Dependent Insulinotropic Polypeptide): Investigated for enhancing insulin sensitivity and fat metabolism
o GLP-1 (Glucagon-Like Peptide-1): Studied for slowing gastric emptying, reducing appetite, and supporting glycemic control
• Together, these pathways are explored for their synergistic effects on metabolic regulation, body composition, and energy balance
Research Insights
• Preclinical and clinical research shows Tirzepatide may significantly improve glucose tolerance and reduce body fat mass
• Studied for potential benefits in obesity, insulin resistance, and cardiovascular health research models
• Demonstrated enhanced weight reduction and metabolic efficiency compared to single-agonist peptides like semaglutide
Potential Research Applications
• Metabolic optimization and weight management models
• Glucose and insulin regulation research
• Peptide synergy studies with compounds like AOD-9604, Cagrilintide, or Retatrutide
⚠️ Disclaimer:
Tirzepatide is intended for laboratory research purposes only.
It is not approved for human use, consumption, or medical treatment.
FOR RESEARCH PURPOSES ONLY
LYOPHILIZED POWDER VIAL
WILL REQUIRE RECONSTITUTION WITH BACTERIOSTATIC WATER, SOLD SEPARATELY